Literature DB >> 22905285

Use of bovine pericardium graft for abdominal wall reconstruction in contaminated fields.

Luigi D'Ambra1, Stefano Berti, Cosimo Feleppa, Prospero Magistrelli, Pierfrancesco Bonfante, Emilio Falco.   

Abstract

AIM: To employ, in such conditions, a biological graft such as bovine pericardium that offers resistance to infection.
METHODS: In our surgical department, from January 2006 to June 2010, 48 patients underwent abdominal wall reconstruction using acellular bovine pericardium; of these 34 patients had a contaminated wound due to diffuse peritonitis (complicated diverticulitis, bowel perforation, intestinal infarction, strangled hernia, etc.) and 14 patients had hernia relapse on infected synthetic mesh.
RESULTS: In our series, one patient died of multi-organ failure 3 d after surgery. After placement of the pericardium mesh four cases of hernia relapse occurred.
CONCLUSION: Recurrence rate is similar to that of prosthetic mesh repair and the application of acellular bovine pericardium (Tutomesh(®), Tutogen Medical Gmbh Germany) is moreover a safe and feasible option that can be employed to manage complicated abdominal wall defects where prosthetic mesh is unsuitable.

Entities:  

Keywords:  Abdominal hernia; Abdominal wall; Bovine pericardium; Contaminated field; hernia relapse

Year:  2012        PMID: 22905285      PMCID: PMC3420984          DOI: 10.4240/wjgs.v4.i7.171

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  14 in total

1.  A comparison of suture repair with mesh repair for incisional hernia.

Authors:  R W Luijendijk; W C Hop; M P van den Tol; D C de Lange; M M Braaksma; J N IJzermans; R U Boelhouwer; B C de Vries; M K Salu; J C Wereldsma; C M Bruijninckx; J Jeekel
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

2.  Long-term complications associated with prosthetic repair of incisional hernias.

Authors:  G E Leber; J L Garb; A I Alexander; W P Reed
Journal:  Arch Surg       Date:  1998-04

3.  Risks associated with "components separation" for closure of complex abdominal wall defects.

Authors:  James B Lowe; Julie B Lowe; Jack D Baty; Jaime R Garza
Journal:  Plast Reconstr Surg       Date:  2003-03       Impact factor: 4.730

4.  Preserved dura and pericardium for closure of large abdominal wall and diaphragmatic defects in children.

Authors:  J M Hutson; A F Azmy
Journal:  Ann R Coll Surg Engl       Date:  1985-03       Impact factor: 1.891

5.  Use of biological meshes for abdominal wall reconstruction in highly contaminated fields.

Authors:  Andrea Cavallaro; Emanuele Lo Menzo; Maria Di Vita; Antonio Zanghì; Vincenzo Cavallaro; Pier Francesco Veroux; Alessandro Cappellani
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

6.  Ventral herniorrhaphy: experience with two different biosynthetic mesh materials, Surgisis and Alloderm.

Authors:  A Gupta; K Zahriya; P L Mullens; S Salmassi; A Keshishian
Journal:  Hernia       Date:  2006-08-22       Impact factor: 4.739

7.  Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia.

Authors:  Jacobus W A Burger; Roland W Luijendijk; Wim C J Hop; Jens A Halm; Emiel G G Verdaasdonk; Johannes Jeekel
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  Use of acellular dermal matrix for complicated ventral hernia repair: does technique affect outcomes?

Authors:  Judy Jin; Michael J Rosen; Jeffrey Blatnik; Michael F McGee; Christina P Williams; Jeffrey Marks; Jeffrey Ponsky
Journal:  J Am Coll Surg       Date:  2007-09-14       Impact factor: 6.113

9.  "Components separation technique" for the repair of large abdominal wall hernias.

Authors:  Tammo S de Vries Reilingh; Harry van Goor; Camiel Rosman; Marc H A Bemelmans; Dick de Jong; Ernst Jan van Nieuwenhoven; Marina I A van Engeland; Robert P Bleichrodt
Journal:  J Am Coll Surg       Date:  2003-01       Impact factor: 6.113

10.  Repair of abdominal wall defects with bovine pericardium.

Authors:  Jonathan N Limpert; Ankit R Desai; Arthur L Kumpf; Michael A Fallucco; Della L Aridge
Journal:  Am J Surg       Date:  2009-10-06       Impact factor: 2.565

View more
  7 in total

1.  Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection.

Authors:  M M Abdelfatah; N Rostambeigi; E Podgaetz; M G Sarr
Journal:  Hernia       Date:  2013-10-16       Impact factor: 4.739

2.  Decellularization and In Vivo Recellularization of Abdominal Porcine Fascial Tissue.

Authors:  Julio C Sánchez; Diana M Díaz; Leidy V Sánchez; Aníbal Valencia-Vásquez; Juan F Quintero; Laura V Muñoz; Andrés F Bernal; Germán Osorio; Álvaro Guerra; Juliana Buitrago
Journal:  Tissue Eng Regen Med       Date:  2020-11-24       Impact factor: 4.169

Review 3.  Biomaterials: so many choices, so little time. What are the differences?

Authors:  John D Hunter; Jamie A Cannon
Journal:  Clin Colon Rectal Surg       Date:  2014-12

4.  Impact of pericardium bovine patch (Tutomesh(®)) on incisional hernia treatment in contaminated or potentially contaminated fields: retrospective comparative study.

Authors:  A Gurrado; I F Franco; G Lissidini; G Greco; M De Fazio; A Pasculli; A Girardi; G Piccinni; V Memeo; M Testini
Journal:  Hernia       Date:  2014-03-01       Impact factor: 4.739

5.  In vivo effects of human adipose-derived stem cells reseeding on acellular bovine pericardium in nude mice.

Authors:  Qingkai Wu; Miao Dai; Peirong Xu; Min Hou; Yincheng Teng; Jie Feng
Journal:  Exp Biol Med (Maywood)       Date:  2015-08-07

6.  The Use of Tutomesh for a Tension-Free and Tridimensional Repair of Uterovaginal and Vaginal Vault Prolapse: Preliminary Report.

Authors:  Danilo Dodero; Luca Bernardini
Journal:  Surg Res Pract       Date:  2015-09-06

7.  Rapid porcine corneal decellularization through the use of sodium N-lauroyl glutamate and supernuclease.

Authors:  Muchen Dong; Long Zhao; Fuyan Wang; Xiaoli Hu; Hua Li; Ting Liu; Qingjun Zhou; Weiyun Shi
Journal:  J Tissue Eng       Date:  2019-09-11       Impact factor: 7.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.